Novel mutations in tyrosine kinase domain of epidermal growth factor receptor in prostate cancer.

被引：0
|
作者：
Douglas, D.
Zhong, H.
Ro, J.
Oddoux, C.
Pincus, M.
Satagopan, J.
Gerald, W.
Schei, H.
Lee, P.
Osman, I.
机构：
[1] NYU, Sch Med, New York, NY USA
[2] Asan Med Ctr, Seoul, South Korea
[3] New York Harbor VA Med Ctr, Brooklyn, NY USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：244S / 244S
页数：1
相关论文
共 50 条
  • [31] Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomas
    R Dahse
    O Driemel
    S Schwarz
    J Dahse
    K Kromeyer-Hauschild
    A Berndt
    H Kosmehl
    British Journal of Cancer, 2009, 100 : 623 - 625
  • [32] Characterization of rare oncogenic mutations in the kinase domain of Epidermal Growth Factor Receptor (EGFR)
    Ruan, Zheng
    Katiyar, Samiksha
    Kannan, Natarajan
    FASEB JOURNAL, 2016, 30
  • [33] Absence of Mutations in the Epidermal Growth Factor Receptor (EGFR) Kinase Domain in Patients with Mesothelioma
    Velcheti, Vamsidhar
    Kasai, Yumi
    Viswanathan, Avinash K.
    Ritter, Jon
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 559 - 559
  • [34] Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein
    Dorai, T
    Gehani, N
    Katz, A
    MOLECULAR UROLOGY, 2000, 4 (01) : 1 - 6
  • [35] Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors
    Harri Sihto
    Marjut Puputti
    Laura Pulli
    Olli Tynninen
    Walter Koskinen
    Leena-Maija Aaltonen
    Minna Tanner
    Tom Böhling
    Tapio Visakorpi
    Ralf Bützow
    Aija Knuuttila
    Nina N. Nupponen
    Heikki Joensuu
    Journal of Molecular Medicine, 2005, 83 : 976 - 983
  • [36] Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors
    Sihto, H
    Puputti, M
    Pulli, L
    Tynninen, O
    Koskinen, W
    Aaltonen, LM
    Tanner, M
    Böhling, T
    Visakorpi, T
    Bützow, R
    Knuuttila, A
    Nupponen, NN
    Joensuu, H
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (12): : 976 - 983
  • [37] Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in Chinese patients with non-small cell lung cancer
    Mu, XL
    Li, LY
    Zhang, XT
    Wang, MZ
    Feng, RE
    Cui, QC
    Zhou, HS
    Guo, BQ
    CLINICAL CANCER RESEARCH, 2005, 11 (12) : 4289 - 4294
  • [38] The human epidermal growth factor receptor (EGFR) gene in European patients with advanced colorectal cancer harbors infrequent mutations in its tyrosine kinase domain
    Metzger, Brigitte
    Chambeau, Laetitia
    Begon, Dominique Y.
    Faber, Carlo
    Kayser, Jacques
    Berchem, Guy
    Pauly, Marc
    Boniver, Jacques
    Delvenne, Philippe
    Dicato, Mario
    Wenner, Thomas
    BMC MEDICAL GENETICS, 2011, 12
  • [39] Gefitinib (iressa)-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in Chinese patients with non-small cell lung cancer
    Mu, X
    Li, L
    Zhang, X
    Wang, M
    Feng, R
    Cui, Q
    Zhou, H
    Guo, B
    LUNG CANCER, 2005, 49 : S110 - S111
  • [40] Specific inhibitor of the epidermal growth factor receptor tyrosine kinase
    Fry, D.W.
    Kraker, A.J.
    McMichael, A.
    Ambroso, L.A.
    Nelson, J.M.
    Leopold, W.R.
    Connors, R.W.
    Bridges, A.J.
    Science, 1994, 265 (5175)
12345